Register entry
SHILPA PHARMA LIFESCIENCES LIMITED
Data as of · How to read this entry
- Registered sites
- 2
- Active NDC listings
- 40
- Live patents
- 0
- Countries
- 1
- Base
- India
Authorisation
Registered operations
Analytical testing2Active ingredient (API) manufacture2
Sites
Registered establishments
2| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| SHILPA PHARMA LIFESCIENCES LIMITED | Plot No.33,33A & 40 to 47, Raichur Industrial Growth Centre, Chicksugur, Raichur, Karnataka 584134, India (IND) | Analytical testing, Active ingredient (API) manufacture | 3007197995915076164 |
| SHILPA PHARMA LIFESCIENCES LIMITED | Plot. No. 1A &1A P, 1B,2,2A,2B,3A to 3E, 4A, 5A,4B & 5B Deosugur Industrial Area, Deosugur, Raichur, Karnataka 584170, India (IND) | Analytical testing, Active ingredient (API) manufacture | 3025560903650439131 |
Catalogue
Drug listings by form and route
4040 active NDC listings: 40 bulk ingredient. By marketing category: BULK INGREDIENT 32, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 8.
| Dosage form | NDCs |
|---|---|
| powder | 40 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| shilpa pharma lifesciences limited | 40 |
Catalogue
Marketed products
40| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Abiratrone Acetate | powder | 82920-040BULK INGREDIENT |
| - | Ambroxol Hydrochloride | powder | 82920-717BULK INGREDIENT |
| - | Axitinib | powder | 82920-028BULK INGREDIENT |
| - | Azacitidine | powder | 82920-015BULK INGREDIENT |
| - | Bendamustine Hydrochloride | powder | 82920-005BULK INGREDIENT |
| - | Bicalutamide | powder | 82920-004BULK INGREDIENT |
| - | Bortezomib | powder | 82920-006BULK INGREDIENT |
| - | Busulfan | powder | 82920-008BULK INGREDIENT |
| - | Capecitabine | powder | 82920-001BULK INGREDIENT |
| - | Clofarabine | powder | 82920-024BULK INGREDIENT |
| - | Cyclophosphamide | powder | 82920-503BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Cyclophosphamide | powder | 82920-708BULK INGREDIENT |
| - | Decitabine | powder | 82920-016BULK INGREDIENT |
| - | Dimethyl Fumarate | powder | 82920-027BULK INGREDIENT |
| - | Erlotinib Hydrochloride | powder | 82920-021BULK INGREDIENT |
| - | Erlotinib Hydrochloride | powder | 82920-200BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Fingolimod Hydrochloride | powder | 82920-019BULK INGREDIENT |
| - | Gemcitabine Hydrochloride | powder | 82920-701BULK INGREDIENT |
| - | Gemcitabine Hydrochloride (Process-2) | powder | 82920-706BULK INGREDIENT |
| - | Ibrutinib | powder | 82920-031BULK INGREDIENT |
| - | Imatinib Mesylate (IMA) | powder | 82920-014BULK INGREDIENT |
| - | Imatinib Mesylate (IMN) | powder | 82920-018BULK INGREDIENT |
| - | Irinotecan Hydrochloride Trihydrate | powder | 82920-702BULK INGREDIENT |
| - | Lenvatinib Mesylate | powder | 82920-036BULK INGREDIENT |
| - | Liraglutide | powder | 82920-504BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Melphalan Hydrochloride | powder | 82920-020BULK INGREDIENT |
| - | Nifedipine | powder | 82920-502BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Nifedipine | powder | 82920-709BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Oxaliplatin | powder | 82920-704BULK INGREDIENT |
| - | Pemetrexed Disodium | powder | 82920-007BULK INGREDIENT |
| - | Phenylephrine Hydrochloride | powder | 82920-710BULK INGREDIENT |
| - | Pirfenidone | powder | 82920-705BULK INGREDIENT |
| - | Prucalopride Succinate | powder | 82920-042BULK INGREDIENT |
| - | Semaglutide | powder | 82920-505BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Sermorelin Acetate | powder | 82920-501BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Sunitinib Malate | powder | 82920-037BULK INGREDIENT |
| - | TEMOZOLOMIDE | powder | 82920-703BULK INGREDIENT |
| - | Tranexamic Acid | powder | 82920-038BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Tranexamic Acid | powder | 82920-045BULK INGREDIENT |
| - | Zoledronic Acid | powder | 82920-012BULK INGREDIENT |
Neighbours
Registered in the same town
1- LARSON PHARMA PRIVATE LIMITEDRaichur, IND
Compare
Comparable companies in India
- MSN Life Sciences Private Limited2 sites · 167 NDC
- Sionc Pharmaceuticals Private Limited2 sites · 56 NDC
- Symbiotec Pharmalab Limited2 sites · 53 NDC
- SMS Pharmaceuticals Limited2 sites · 46 NDC
- DIVI'S LABORATORIES LIMITED2 sites · 45 NDC
- Chromo Laboratories India Private Limited2 sites · 44 NDC
- SOFTGEL HEALTHCARE PRIVATE LIMITED2 sites · 38 NDC
- Teva API India Private Ltd.2 sites · 36 NDC
- Hikal Limited2 sites · 35 NDC
- Optimus Drugs Private Limited2 sites · 32 NDC
Enquiry
Common questions
- Is SHILPA PHARMA LIFESCIENCES LIMITED FDA approved?
- SHILPA PHARMA LIFESCIENCES LIMITED holds 2 FDA-registered establishments in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are SHILPA PHARMA LIFESCIENCES LIMITED's drugs manufactured?
- The FDA register lists Raichur. Registered operations: analytical testing, active ingredient (API) manufacture.
- What drugs does SHILPA PHARMA LIFESCIENCES LIMITED make?
- 40 products are listed under SHILPA PHARMA LIFESCIENCES LIMITED in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.